Lyra Therapeutics, Inc.
Richard Nieman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard Nieman
The proxy statement of Lyra Therapeutics, Inc. reports total compensation of $1,399,467 for Richard Nieman in fiscal 2022, including a base salary of $205,625.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Lyra Therapeutics, Inc.
Proxy statement
Start not stated–2024-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Lyra Therapeutics, Inc. | Chief Medical Officer | $205,625 | $1,399,467 |
Recent activity
No call appearances or filed executive changes recorded yet.